|
Market Closed -
London S.E.
16:35:18 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 72.50 GBX | 0.00% |
|
-18.08% | -9.94% |
| 09-30 | Arecor Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 09-30 | EARNINGS: Arecor fundraise as loss widens; Northcoders' B2B progress | AN |
| Market Cap | 27.37M 36.22M 32.18M 30.03M 51.63M 3.48B 52.11M 363M 141M 1.78B 136M 133M 5.71B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.05M 34.47M 30.63M 28.58M 49.14M 3.31B 49.59M 346M 134M 1.69B 129M 127M 5.44B | EV / Sales 2026 * |
29.7x | EV / Sales 2027 * | 29.1x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AREC | Delayed | |
Deutsche Boerse AG
| 6UI | Delayed | |
|
Börse Stuttgart
| 6UI | Delayed |
Last Transcript: Arecor Therapeutics plc
| 1 week | -18.08% | ||
| 1 month | -2.03% | ||
| 3 months | +14.17% | ||
| 6 months | +9.85% | ||
| Current year | -9.94% |
| 1 week | 70 |  | 90 |
| 1 month | 70 | | 90 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 95 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 449 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 12/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 17/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 12/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 31/08/2017 |
Andrew Richards
CHM | Chairman | 66 | 12/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Chief Executive Officer | 160,000 | 0.4238% | ||
| 20/05/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 20/05/26 | Free | Chief Financial Officer | 105,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -18.08% | -16.18% | -62.34% | 36.16M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -1.24% | -4.59% | +26.24% | +33.05% | 42.91B | |
| +0.43% | +0.68% | +351.58% | +688.57% | 44.13B | |
| -1.56% | -2.61% | +1.81% | +96.88% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| -0.06% | -8.05% | -29.09% | +327.08% | 23.71B | |
| Average | -0.37% | -2.39% | +45.25% | +135.64% | 39.25B | |
| Weighted average by Cap. | -0.07% | -0.40% | +57.23% | +149.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.16M 1.03M 964K 1.66M 112M 1.67M 11.66M 4.52M 57.12M 4.36M 4.27M 183M | 1.05M 1.39M 1.23M 1.15M 1.98M 134M 2M 13.94M 5.4M 68.27M 5.22M 5.1M 219M |
| Net income | - | - |
| Net Debt | -1.32M -1.75M -1.55M -1.45M -2.49M -168M -2.51M -17.52M -6.79M -85.81M -6.56M -6.41M -275M | 3.2M 4.24M 3.77M 3.51M 6.04M 407M 6.1M 42.53M 16.48M 208M 15.91M 15.56M 668M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | GBX 72.50 | 0.00% | 29,196 |
| 01/10/26 | GBX 72.50 | 0.00% | 30,324 |
| 30/09/26 | GBX 72.50 | -18.08% | 94,553 |
| 29/09/26 | GBX 88.50 | 0.00% | 64,951 |
| 28/09/26 | GBX 88.50 | 0.00% | 23,501 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7250GBP
Average target price
2.755GBP
Spread / Average Target
+280.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
